amifostine anhydrous has been researched along with Myocardial Ischemia in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rolleman, EJ | 1 |
Forrer, F | 1 |
Deckers, J | 1 |
de Groot, H | 1 |
Valkema, R | 1 |
de Jong, M | 1 |
Krenning, EP | 1 |
1 other study available for amifostine anhydrous and Myocardial Ischemia
Article | Year |
---|---|
Anaphylactoid reaction from amifostine.
Topics: Amifostine; Diagnosis, Differential; Humans; IgA Vasculitis; Myocardial Ischemia; Radiation-Protecti | 2007 |